Bartira Rossi-Bergmann

5PUBLICATIONS
22CO-AUTHORS
Biologically active moleculesCheminformatics and quantitative structure-activity relationshipsBiomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 26, 2026
Cross-Species Hepatic Metabolism of the Antileishmanial Chalcone NAT22 Generates Metabolites with Predicted Enhanced Affinity for the Parasite Target cTXNPx.

|Dec 04, 2023
Synthesis and evaluation of hybrid sulfonamide-chalcones with potential antileishmanial activity.

Nathalia S de Oliveira, Luana G de Souza, Vitor M de Almeida

|Nov 15, 2021
Chalcones identify cTXNPx as a potential antileishmanial drug target.

Douglas O Escrivani, Rebecca L Charlton, Marjolly B Caruso

|Jul 02, 2021
MPLA and AddaVax® Adjuvants Fail to Promote Intramuscular LaAg Vaccine Protectiveness against Experimental Cutaneous Leishmaniasis.

Diogo Oliveira-Maciel, Júlio Souza Dos-Santos, Gabriel Oliveira-Silva

|Jul 18, 2018
Broad Spectrum and Safety of Oral Treatment with a Promising Nitrosylated Chalcone in Murine Leishmaniasis.

Ariane J Sousa-Batista, Douglas Escrivani-Oliveira, Camila Alves Bandeira Falcão

Pageof 1

Frequent Collaborators

2 joint publications

Alcides Monteiro da Silva

2 joint publications

Osvaldo A Santos-Filho

2 joint publications

Vitor M de Almeida

2 joint publications

Alessandra M T Souza